GlassScriptPhysician profile
Florence Harris
NPI 1720536261
$924.40
in general payments reported to CMS, 2019-2025
19 companies · $485 in 2025
The $485 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.81 · 2022: $10.63 · 2023: $69.86 · 2024: $322 · 2025: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $159.86 | 2023-2025 | Veozah |
| Biogen, INC. | $125.84 | 2025 | Zurzuvae |
| Organon LLC | $79.28 | 2022-2025 | Jada System, Nexplanon |
| Evofem Biosciences, INC. | $59.91 | 2024-2025 | Phexxi, Solosec, Phexx |
| Merck Sharp & Dohme LLC | $55.66 | 2021-2024 | Gardasil 9, Gardasil |
| Daiichi Sankyo INC. | $51.87 | 2025 | Injectafer |
| Hologic Sales and Service, LLC | $50.31 | 2021-2024 | Myosure Tissue Removal Device |
| Mayne Pharma Commercial LLC | $46.10 | 2025 | |
| Abbvie INC. | $41.14 | 2024-2025 | |
| Pfizer INC. | $35.26 | 2024-2025 | |
| Millicent US INC | $34.30 | 2025 | Femlyv, Intrarosa |
| Ethicon US, LLC | $31.38 | 2025 | Ethicon |
| Shield Therapeutics INC | $29.67 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.50 | 2024 | |
| Aspira Women'S Health INC | $21.60 | 2024 | Ova1 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $20.96 | 2023 | Citranatal |
| Coopersurgical, INC. | $19.05 | 2024 | Paragard T 380a |
| Sanofi Pasteur INC. | $18.95 | 2024 | |
| Seqirus USA INC | $18.76 | 2024 | Flucelvax, Fluad |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Florence Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.